Viewing Study NCT00990912


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-03 @ 4:06 PM
Study NCT ID: NCT00990912
Status: COMPLETED
Last Update Posted: 2010-02-05
First Post: 2009-10-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module